Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy

The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Bernd J. Krause, Michael Souvatzoglou, Murat Tuncel et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 367 citations

Medicine, Nuclear Medicine, Oncology +17

[18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients

M. Cimitan, Roberto Bortolus, Sandro Morassut et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 312 citations

Medicine, Nuclear Medicine, Radiology +14

Value of [ ¹¹ C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ ¹⁸ F]fluorodeoxyglucose-Positron Emission Tomography

Maria Picchio, C. Messa, Claudio Landoni et al. · The Journal of Urology · 2003 · 305 citations

Medicine, Oncology, Radiology +17

Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy.

Michael L. Cher, Fernando J. Bianco, J. Lam et al. · PubMed · 1998 · 228 citations

Medicine, Nuclear Medicine, Urology +16

PSA Doubling Time as a Predictor of Clinical Progression After Biochemical Failure Following Radical Prostatectomy for Prostate Cancer

Steven G. Roberts, Michael L. Blute, Erik J. Bergstralh et al. · Mayo Clinic Proceedings · 2001 · 224 citations

Medicine, Oncology, Urology +17